Centrus Energy’s Nuclear Expansion
Jan 1, 2026 By MarketDepth
Centrus Energy Corp. (NYSE: LEU), a U.S. nuclear fuel supplier, has been grabbing investor attention as it transitions from a niche enrichment services provider into a more scalable commercial business. Recently the company began domestic centrifuge manufacturing at its Piketon, Ohio facility—an important step toward industrial‑scale production of low‑enriched uranium (LEU) that’s expected to support both traditional reactors and emerging advanced nuclear projects. This strategic shift represents one of the most consequential transformations in the U.S. uranium supply chain in years and has helped propel Centrus’ stock sharply higher, with the company outperforming many peers and broader energy benchmarks in 2025.
Investors have responded to the news with bullish sentiment, reflected in analyst price target revisions and institutional buying. Just this week, B. Riley raised its price target on Centrus shares from $221 to $315, maintaining a Buy rating as the company accelerates its expansion plans. Meanwhile, institutional investment activity shows new positions being taken, including recent share purchases by Moody Aldrich Partners—signaling continued conviction among sophisticated market players.
The broader context for Centrus’ stock performance includes strong demand for securing domestic nuclear fuel supply amid geopolitical pressures on imported uranium and increasing interest in clean energy sources that complement evolving power grids. The company’s multi‑billion‑dollar backlog of contingent LEU sales to U.S. and international customers highlights tangible commercial demand that could underpin future revenue growth.
